X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (19112) 19112
Publication (1755) 1755
Newsletter (646) 646
Book Review (170) 170
Book Chapter (96) 96
Newspaper Article (52) 52
Magazine Article (45) 45
Dissertation (27) 27
Conference Proceeding (18) 18
Trade Publication Article (8) 8
Data Set (4) 4
Web Resource (4) 4
Government Document (3) 3
Book / eBook (2) 2
Transcript (2) 2
Paper (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (13650) 13650
ribavirin (10579) 10579
index medicus (8200) 8200
antiviral agents - therapeutic use (7884) 7884
male (7864) 7864
female (7564) 7564
hepatitis c, chronic - drug therapy (7036) 7036
hepatitis c (6852) 6852
middle aged (6541) 6541
ribavirin - therapeutic use (6490) 6490
adult (5904) 5904
gastroenterology & hepatology (5742) 5742
interferon (5249) 5249
drug therapy, combination (5222) 5222
hepatitis c virus (5146) 5146
interferon-alpha - therapeutic use (4756) 4756
treatment outcome (4715) 4715
hepacivirus - genetics (3894) 3894
genotype (3535) 3535
recombinant proteins (3206) 3206
therapy (3113) 3113
plus ribavirin (3000) 3000
infection (2916) 2916
aged (2901) 2901
antiviral agents - administration & dosage (2901) 2901
hepatitis c - drug therapy (2783) 2783
ribavirin - administration & dosage (2771) 2771
virus-infection (2736) 2736
infectious diseases (2716) 2716
health aspects (2715) 2715
polyethylene glycols - therapeutic use (2696) 2696
hepatitis (2634) 2634
virology (2537) 2537
antiviral agents - adverse effects (2460) 2460
hepatitis c, chronic - virology (2373) 2373
hepacivirus - drug effects (2274) 2274
care and treatment (2192) 2192
biological response modifiers (2165) 2165
interferon-alpha - administration & dosage (2066) 2066
pharmacology & pharmacy (2064) 2064
antiviral agents (2004) 2004
viral load (1945) 1945
hcv (1857) 1857
ribavirin - adverse effects (1826) 1826
drug therapy (1761) 1761
pegylated interferon (1687) 1687
virus diseases (1682) 1682
sustained virological response (1681) 1681
interferon-alpha - adverse effects (1674) 1674
hepatitis c, chronic - complications (1651) 1651
liver (1606) 1606
analysis (1604) 1604
rna, viral - blood (1524) 1524
chronic hepatitis c (1510) 1510
cirrhosis (1459) 1459
combination therapy (1454) 1454
genetic aspects (1450) 1450
chronic hepatitis-c (1426) 1426
antiviral agents - pharmacology (1415) 1415
infections (1393) 1393
immunology (1389) 1389
research (1371) 1371
recombinant proteins - therapeutic use (1361) 1361
retrospective studies (1348) 1348
risk factors (1342) 1342
viruses (1328) 1328
animals (1299) 1299
virus (1255) 1255
combination (1233) 1233
peginterferon (1207) 1207
polyethylene glycols - administration & dosage (1183) 1183
medicine, general & internal (1157) 1157
sofosbuvir (1154) 1154
peginterferon alpha-2a (1149) 1149
time factors (1143) 1143
initial treatment (1124) 1124
interferons - therapeutic use (1124) 1124
antiviral therapy (1120) 1120
adolescent (1072) 1072
microbiology (1056) 1056
interferon-alpha (1052) 1052
hepacivirus - isolation & purification (1051) 1051
rna (1051) 1051
young adult (1043) 1043
gastroenterology and hepatology (1038) 1038
patients (1027) 1027
ribavirin - pharmacology (1021) 1021
genotypes (1014) 1014
recurrence (1008) 1008
transplantation (1007) 1007
prospective studies (989) 989
hiv (974) 974
telaprevir (963) 963
hepatitis c - virology (960) 960
hepatitis c - complications (958) 958
fibrosis (955) 955
hiv infections - complications (951) 951
efficacy (948) 948
liver cirrhosis (948) 948
hepatocellular-carcinoma (943) 943
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (18466) 18466
French (274) 274
Spanish (252) 252
German (175) 175
Korean (158) 158
Japanese (146) 146
Chinese (114) 114
Russian (93) 93
Polish (91) 91
Hungarian (46) 46
Portuguese (30) 30
Italian (19) 19
Croatian (18) 18
Turkish (18) 18
Czech (15) 15
Serbian (11) 11
Dutch (8) 8
Danish (7) 7
Arabic (3) 3
Finnish (3) 3
Hebrew (3) 3
Norwegian (3) 3
Slovak (3) 3
Bosnian (2) 2
Lithuanian (2) 2
Persian (2) 2
Romanian (2) 2
Swedish (2) 2
Icelandic (1) 1
Slovenian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2015, Volume 386, Issue 10003, pp. 1537 - 1545
Journal Article
Addiction, ISSN 0965-2140, 01/2012, Volume 107, Issue 1, pp. 152 - 159
Journal Article
Lancet, The, ISSN 0140-6736, 2015, Volume 385, Issue 9986, pp. 2502 - 2509
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2014, Volume 370, Issue 17, pp. 1594 - 1603
In this trial in previously untreated patients with HCV genotype 1 infection and no cirrhosis, high rates of sustained response were achieved with three new... 
TRIAL | MEDICINE, GENERAL & INTERNAL | PLUS SOFOSBUVIR | C VIRUS-INFECTION | GENOTYPE 1 INFECTION | DACLATASVIR | SIMEPREVIR TMC435 | HEPATITIS-C | INTERFERON-FREE | TREATMENT-NAIVE PATIENTS | PHASE 2B | Anilides - therapeutic use | Anilides - adverse effects | Humans | Middle Aged | Hepacivirus - genetics | Hepatitis C, Chronic - virology | Male | Viral Load | Young Adult | Ritonavir - adverse effects | Ritonavir - therapeutic use | Adult | Female | Double-Blind Method | Antiviral Agents - therapeutic use | Ribavirin - therapeutic use | Uracil - therapeutic use | Macrocyclic Compounds - adverse effects | Hepatitis C, Chronic - drug therapy | Macrocyclic Compounds - therapeutic use | Uracil - adverse effects | Sulfonamides - therapeutic use | Ribavirin - adverse effects | Antiviral Agents - adverse effects | Adolescent | Sulfonamides - adverse effects | Carbamates - adverse effects | Aged | Carbamates - therapeutic use | Drug Combinations | Uracil - analogs & derivatives | Dosage and administration | Research | Drug therapy, Combination | Hepatitis C | Drug therapy | Ribavirin | Ritonavir | Body weight | Diarrhea | Infections | Nausea | Proteinase inhibitors | Pruritus | Drug resistance | Patients | Genotype & phenotype | Cirrhosis | Sleep disorders | Hepatitis | Asthenia | Hemoglobin | Interferon | Drug dosages | Genotypes
Journal Article
Journal of Hepatology, ISSN 0168-8278, 2013, Volume 59, Issue 3, pp. 434 - 441
Journal Article
Annals of Internal Medicine, ISSN 0003-4819, 2012, Volume 156, Issue 4, pp. 279 - 290
Journal Article
Liver International, ISSN 1478-3223, 06/2018, Volume 38, Issue 6, pp. 1010 - 1021
Background & Aims We report data from two similarly designed studies that evaluated the efficacy, safety, and optimal duration of ledipasvir/sofosbuvir... 
ledipasvir | sofosbuvir | treatment‐experienced | HCV | HIV | treatment-experienced | PLUS RIBAVIRIN | LEDIPASVIR-SOFOSBUVIR | OPEN-LABEL | HCV INFECTION | CIRRHOSIS | GENOTYPE 1 INFECTION | GASTROENTEROLOGY & HEPATOLOGY | ADVANCED LIVER-DISEASE | PHASE-2 TRIAL | Uridine Monophosphate - administration & dosage | Headache - etiology | Coinfection - drug therapy | Humans | Middle Aged | Fatigue - etiology | Hepacivirus - genetics | Male | Benzimidazoles - administration & dosage | Ribavirin - administration & dosage | Adult | Female | Fluorenes - administration & dosage | Fluorenes - adverse effects | Uridine Monophosphate - adverse effects | Benzimidazoles - adverse effects | HIV Infections - virology | Liver Cirrhosis | Hepatitis C, Chronic - drug therapy | Antiviral Agents - administration & dosage | Coinfection - virology | Pregnancy | Ribavirin - adverse effects | Antiviral Agents - adverse effects | Uridine Monophosphate - analogs & derivatives | HIV Infections - drug therapy | Aged | Sustained Virologic Response | Headache | Medical research | Clinical trials | Viruses | Fatigue | Infections | Ribavirin | Cirrhosis | Hepatitis | Randomization | Inhibitors | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV | Adults | Interferon | Hepatitis C virus | Hepatitis C | Genotypes | Treatment-experienced | Sofosbuvir | Ledipasvir
Journal Article
JAMA, ISSN 0098-7484, 08/2013, Volume 310, Issue 8, pp. 804 - 811
Journal Article